Safety/Tolerability/Pharmacokinetic (PK)/Pharmacodynamics (PD) Study of BMN701 in Patients With Late-Onset Pompe Disease
Clinical trial NCT01230801 · COMPLETED
Trial details
- NCT number
- NCT01230801
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-17
- Primary completion
- 2013-03-06
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.